Clinical significance of high-mobility group box-1 (HMGB1) in subjects with type 2 diabetes mellitus (T2DM) combined with chronic obstructive pulmonary disease (COPD)
Autor: | Yongjian Tian, Jianlin Yu, Jiayi Huang, Tingting Zeng, Zihuan Pei, Liming Tan, Yang Wu |
---|---|
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Male Vital capacity endocrine system diseases type 2 diabetes mellitus Clinical Biochemistry independent risk factor Gastroenterology chemistry.chemical_compound Pulmonary Disease Chronic Obstructive 0302 clinical medicine Immunology and Allergy HMGB1 Protein Research Articles COPD Hematology Middle Aged Respiratory Function Tests Medical Laboratory Technology medicine.anatomical_structure 030220 oncology & carcinogenesis Regression Analysis Female Research Article Microbiology (medical) medicine.medical_specialty chronic obstructive pulmonary disease 03 medical and health sciences FEV1/FVC ratio Internal medicine White blood cell medicine Humans Clinical significance Risk factor Aged high‐mobility group box‐1 business.industry Biochemistry (medical) Public Health Environmental and Occupational Health Type 2 Diabetes Mellitus nutritional and metabolic diseases medicine.disease type 2 diabetes mellitus combined with chronic obstructive pulmonary disease respiratory tract diseases 030104 developmental biology chemistry Diabetes Mellitus Type 2 Case-Control Studies Glycated hemoglobin Insulin Resistance business |
Zdroj: | Journal of Clinical Laboratory Analysis |
ISSN: | 1098-2825 |
Popis: | Background Simple method to predict type 2 diabetes mellitus (T2DM) combined with chronic obstructive pulmonary disease (COPD) is in great need clinically. This study aims to assess the clinical significance of high‐mobility group box‐1 (HMGB1) in predicting T2DM combined with COPD in Chinese patients with T2DM or COPD. Methods Serum concentrations of glycated hemoglobin (HbA1C), fasting plasma glucose (FPG), fasting insulin (FINS), total cholesterol (TC), triglyceride (TG), low‐density lipoprotein cholesterol (LDL‐c), high‐density lipoprotein cholesterol (HDL‐c), C‐reactive protein (CRP), fibrinogen (FIB), HMGB1, white blood cell count (WBC), neutrophil% (NEU%), and lung function text such as forced expiratory volume 1/forced vital capacity (FEV1/FVC) and forced expiratory volume 1% predicted value (FEV1%pred) were measured in 126 T2DM patients, 118 COPD patients, 112 T2DM combined with COPD patients, and 120 healthy controls. Logistic regression was used to estimate the risk factors for T2DM combined with COPD. Results High‐mobility group box‐1 elevated in patients with T2DM combined with COPD, significantly higher than other subjects (P |
Databáze: | OpenAIRE |
Externí odkaz: |